FBInvestor
Funds / Virtus Investment Advisers, LLC
Institutional Fund

Virtus Investment Advisers, LLC

Hartford, CTCIK 194815 filings on record

Portfolio Value
$362.53M
Q1 2026
Holdings
450
Reported positions
New Buys
36
Opened this quarter
QoQ Change
-1.5%
from $367.93M

Portfolio Value Trend

Reported 13F value by quarter

Portfolio value trend — upgrade to see history

Upgrade

Top Allocations

Largest positions by weight

  • Gilead Sciences Inc0.8%
  • Amgen Inc0.8%
  • Regeneron Pharmaceuticals0.8%
  • Immunitybio Inc0.8%
  • Vertex Pharmaceuticals Inc0.7%
  • Incyte Corp0.7%
  • Other95.5%

Portfolio Holdings

450 positions · Q1 2026

#SecuritySharesValue% Port.Δ SharesActivity
1Gilead Sciences Inc20.5K$2.85M0.8%+14.8KAdded
2Amgen Inc8.1K$2.83M0.8%+5.9KAdded
3Regeneron Pharmaceuticals3.6K$2.78M0.8%+2.7KAdded
4Immunitybio Inc357.7K$2.74M0.8%+68.2KAdded
5Vertex Pharmaceuticals Inc5.9K$2.62M0.7%+4.4KAdded
6Incyte Corp27.2K$2.56M0.7%785Reduced
7Vertiv Holdings Co10.0K$2.51M0.7%+21Added
8Alnylam Pharmaceuticals Inc7.5K$2.47M0.7%+5.8KAdded
9Edison Intl33.0K$2.41M0.7%+30.3KAdded
10Ross Stores Inc10.2K$2.21M0.6%1.7KReduced

440 more holdings on Premium

See this fund's complete portfolio, full position changes, and activity history.

Unlock full portfolio